These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 27399806)

  • 1. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
    Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I
    Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of AMA0428, a novel and potent ROCK inhibitor, in a model of neovascular age-related macular degeneration.
    Hollanders K; Van Bergen T; Kindt N; Castermans K; Leysen D; Vandewalle E; Moons L; Stalmans I
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1335-48. PubMed ID: 25626969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of placental growth factor as a novel treatment option in diabetic retinopathy.
    Van Bergen T; Hu TT; Etienne I; Reyns GE; Moons L; Feyen JHM
    Exp Eye Res; 2017 Dec; 165():136-150. PubMed ID: 28965804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling.
    Zhu L; Wang W; Xie TH; Zou J; Nie X; Wang X; Zhang MY; Wang ZY; Gu S; Zhuang M; Tan J; Shen C; Dai Y; Yang X; Yao Y; Wei TT
    FASEB J; 2020 Mar; 34(3):4189-4203. PubMed ID: 31957105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
    Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
    Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
    Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of elema-1,3,7(11),8-tetraen-8,12-lactam from Curcuma wenyujin on diabetic retinopathy via anti-inflammatory and anti-angiogenic pathways.
    Cai Y; Tu H; Wu C; Liu T; Chen S; Shen L; Xiao Q; Zhao S; Xu S; Lin W; Yan P; Dong J
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116843. PubMed ID: 37414197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes.
    Li J; Wang P; Ying J; Chen Z; Yu S
    Cell Physiol Biochem; 2016; 39(3):1196-208. PubMed ID: 27595397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
    Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A key role for ROCK in TNF-α-mediated diabetic microvascular damage.
    Arita R; Nakao S; Kita T; Kawahara S; Asato R; Yoshida S; Enaida H; Hafezi-Moghadam A; Ishibashi T
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2373-83. PubMed ID: 23462755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
    Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
    J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF164 is proinflammatory in the diabetic retina.
    Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho-Associated Protein Kinase-1 Mediates the Regulation of Inflammatory Markers in Diabetic Retina and in Retinal Müller Cells.
    Mohammad G; AlSharif HM; Siddiquei MM; Ahmad A; Alam K; Abu El-Asrar AM
    Ann Clin Lab Sci; 2018 Mar; 48(2):137-145. PubMed ID: 29678838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: Association with the NF-κB signaling pathway.
    Wang Y; Sun X; Xie Y; Du A; Chen M; Lai S; Wei X; Ji L; Wang C
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117135. PubMed ID: 37689326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Andrographolide ameliorates diabetic retinopathy by inhibiting retinal angiogenesis and inflammation.
    Yu Z; Lu B; Sheng Y; Zhou L; Ji L; Wang Z
    Biochim Biophys Acta; 2015 Apr; 1850(4):824-31. PubMed ID: 25641276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF promotes diabetic retinopathy by upregulating the PKC/ET/NF-κB/ICAM-1 signaling pathway.
    Zhang M; Zhou M; Cai X; Zhou Y; Jiang X; Luo Y; Hu Y; Qiu R; Wu Y; Zhang Y; Xiong Y
    Eur J Histochem; 2022 Oct; 66(4):. PubMed ID: 36305269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.